Onconetix Faces Delisting Concerns

Ticker: ONCO · Form: 8-K · Filed: Apr 30, 2025 · CIK: 1782107

Sentiment: bearish

Topics: delisting, listing-standards, corporate-actions

TL;DR

Onconetix might get kicked off the exchange - big trouble.

AI Summary

Onconetix, Inc. filed an 8-K on April 30, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company, formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc., is incorporated in Delaware and headquartered in Cincinnati, Ohio.

Why It Matters

This filing indicates potential issues with Onconetix, Inc.'s ability to remain listed on its current exchange, which could impact its stock liquidity and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards suggests significant financial or operational distress for the company.

Key Players & Entities

FAQ

What specific listing rule or standard has Onconetix, Inc. failed to satisfy?

The filing does not specify the exact rule or standard that Onconetix, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.

What is the exact date of the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on April 24, 2025.

When was Onconetix, Inc. previously known as Blue Water Biotech, Inc. and when did the name change occur?

Onconetix, Inc. was formerly known as Blue Water Biotech, Inc., and the date of that name change was April 24, 2023.

What is the principal executive office address for Onconetix, Inc.?

The principal executive office address for Onconetix, Inc. is 201 E. Fifth Street, Suite 1900, Cincinnati, Ohio 45202.

What is the Commission File Number for Onconetix, Inc.?

The Commission File Number for Onconetix, Inc. is 001-41294.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 30, 2025 regarding Onconetix, Inc. (ONCO).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing